The hearing aid market in France has been operating since 2021 under a dual pricing system, that of 100% Santé and that of freely priced devices. At Audika, a subsidiary of the Demant group, this duality results in sometimes confusing price differences for patients. Understanding what separates a device billed at the minimum price from a high-end model requires looking into reimbursement mechanisms, renewal constraints, and practical practices in the center.
Class 1 and Class 2 at Audika: what the price difference really covers
The pricing structure at Audika is based on the regulatory distinction between two classes of devices. Hearing aids of class 1, capped at 950 euros per ear, fall under the 100% Santé scheme. With a responsible complementary insurance, the out-of-pocket cost for the patient is zero.
Class 2 devices, which are freely priced, can significantly exceed this threshold. The price increases based on the level of signal processing, connectivity options (Bluetooth, wireless charging), and the degree of customization of the settings by the audioprosthetist. A detailed comparison of the prices of hearing aids at Audika allows for measuring the actual range between the two classes.
The point that commercial communications tend to downplay concerns the exact nature of the services included. The price displayed by Audika covers the device, but also the adjustment sessions, follow-up over several years, and the warranty. The cost of the device alone represents only a fraction of the total bill, the rest corresponding to audioprosthetic support.
Renewal every four years: a rule more rigid than it seems
The full coverage of a new fitting by Social Security and the mutual insurance follows a four-year period calculated from date to date on the previous invoice. A purchase made in March 2024 blocks any new reimbursement until March 2028, except for documented medical exceptions (deterioration of hearing, irreparable breakdown, loss or theft).
This rule creates a concrete situation for Audika patients: changing models before the four-year deadline means bearing the full cost. Feedback relayed by patient associations has reported since 2024-2025 an increase in refusals or adjustments of coverage in cases of early renewal.
For a patient whose hearing loss is progressing rapidly, this time lock can pose a real problem. Audika centers sometimes offer interim solutions (adjustment of settings, change of ear tips), but the complete replacement of the device remains subject to this administrative schedule.
Exceptions to the four-year deadline
- A significant and medically certified deterioration of hearing, documented by an ENT specialist, may justify early coverage from the health insurance fund.
- An irreparable breakdown of the device, certified by the audioprosthetist, entitles one to renewal before the term under certain conditions.
- The loss or theft of the hearing aid, reported and justified, constitutes another reason for exception, even if processing times vary according to the funds.
30-day free trial: what the legal framework really guarantees
Since 2024, Health Insurance has clarified that the right to a trial of at least 30 days free of charge applies to all audioprosthetists within the framework of the 100% Santé pathway. Audika communicates about this trial, which allows testing the device in real conditions before committing.
This trial period does not mean total absence of constraints. The patient must return the devices in good condition to owe nothing. The question also arises regarding class 2 devices: the free trial concerns the 100% Santé pathway, and the conditions for high-end models may differ from one Audika center to another.
Field feedback varies on this point. Some patients report an extended trial to class 2 without difficulty, while others indicate that they were exclusively offered class 1 models during the trial period, before being directed towards higher ranges. The regulatory framework protects the patient, but practice varies by center.
Audika versus independent audioprosthetists: the question of real price
The catalog price is not enough to compare Audika with an independent audioprosthetist. At a large chain, the cost includes the structure (rent in a shopping center, reception staff, national advertising campaigns). At an independent, structural costs are generally lower, which can be reflected in the price of class 2 devices.
In class 1, the comparison loses relevance since the price is capped and the out-of-pocket cost is zero. It is in class 2 that the gap widens. The same device, from the same manufacturer, can be offered at different prices depending on the chain, as the selling price in class 2 is freely set by each audioprosthetist.
- At an Audika center, the price includes standardized follow-up during the warranty period (four years), with scheduled adjustment appointments.
- At an independent, the follow-up may be more flexible or personalized, but the warranty conditions and frequency of adjustments vary.
- The choice of available models also depends on agreements between the chain and manufacturers, with Audika being linked to the Demant group.
What the price does not say about the quality of the fitting
A hearing aid well adjusted by a competent audioprosthetist yields better results than a more expensive model poorly fitted. The determining factor remains the quality of the initial assessment, the precision of the adjustments, and the regularity of follow-up. A class 1 device properly adjusted covers the majority of mild to moderate hearing losses.
The choice between Audika and another hearing professional should therefore not rest solely on the displayed price. The geographical proximity of the center, the availability of the audioprosthetist for adjustment appointments, and transparency regarding the standardized quote weigh as much as the price itself in the success of a fitting.
